March 30 (Reuters) - Forma Therapeutics Holdings Inc :
* FORMA THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CURRENT CASH RUNWAY IS PROJECTED THROUGH Q3 OF 2024
* QTRLY LOSS PER SHARE $0.68
* Q4 EARNINGS PER SHARE VIEW $-0.80 -- REFINITIV IBES DATA
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* FORMA THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CURRENT CASH RUNWAY IS PROJECTED THROUGH Q3 OF 2024
* QTRLY LOSS PER SHARE $0.68
* Q4 EARNINGS PER SHARE VIEW $-0.80 -- REFINITIV IBES DATA
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)